Public Genome Governance Doctrine

Introduction

The Public Genome Governance Doctrine is an emerging legal and ethical framework for regulating genomic science in the public interest. It concerns genome sequencing, genetic testing, genome editing, genetic-data collection, and the use of genetically modified organisms.

The doctrine is not a single, formally codified legal rule. Rather, it draws upon constitutional rights, biomedical ethics, environmental law, privacy principles, and public accountability. Its objective is to ensure that genomic technologies are developed and applied safely, transparently, and fairly, while protecting human dignity, autonomy, privacy, and the interests of future generations.

Constitutional and Legal Framework

In India, Article 21 protects life, personal liberty, dignity, and privacy. Article 14 requires equality and non-arbitrary state action. Article 19 may protect scientific research and expression, subject to constitutional restrictions. Articles 48A and 51A(g) support environmental protection.

The doctrine requires that genomic governance include:

Informed consent: Individuals should understand the purpose, risks, and possible consequences of genetic testing or intervention.

Genetic privacy: Genomic data must be protected from unauthorized collection, disclosure, and misuse.

Biosafety: Genome technologies require appropriate scientific risk assessment and monitoring.

Transparency: Regulatory decisions should be reasoned and open to appropriate scrutiny.

Public participation: Decisions with broad social or environmental effects should involve meaningful consultation.

Accountability: Institutions must comply with legal standards and provide remedies where unlawful conduct causes harm.

Important Case Laws

1. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court recognized privacy as a fundamental right, including informational privacy, dignity, and personal autonomy. It held that interference with privacy must satisfy legality, a legitimate purpose, and proportionality.

privacylibrary.ccgnlud.org+1

Relevance: Genomic information may reveal health risks, ancestry, and familial relationships. The judgment provides a constitutional foundation for protecting genetic data from unjustified collection or disclosure.

2. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court explained that valid medical consent must be voluntary and based on adequate information. Consent to one procedure does not automatically authorize a materially different procedure.

Relevance: Genetic testing and genome editing require clear information about their purpose, risks, limitations, and consequences. Institutions should not treat consent for one clinical procedure as unrestricted permission for unrelated research or future data use.

3. Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognized the precautionary principle and the polluter-pays principle as important components of Indian environmental law.

Relevance: Where release of a genetically modified organism may pose serious environmental risks, regulators should assess risks before permitting release. Scientific uncertainty does not automatically justify ignoring credible risks.

4. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999) 2 SCC 718

The Supreme Court emphasized the importance of scientific expertise in environmental decision-making and recognized the challenges courts face when evaluating complex technical evidence.

Relevance: Genomic and biotechnology decisions should be based on competent scientific assessment, transparent reasoning, and appropriate expert review. Scientific complexity should not prevent regulatory accountability.

5. Gene Campaign v. Union of India (2024) 2024 INSC 545

The Supreme Court considered challenges relating to genetically modified mustard, DMH-11. The Court agreed that regulatory decisions concerning genetically modified organisms are subject to judicial review and directed the Union Government to formulate a national policy on GM crops. The judges differed on the validity of the specific approval, which was referred for further consideration.

Manupatra eNewsLine+1

Relevance: The case illustrates the importance of biosafety review, reasoned regulatory decisions, public consultation, and judicial scrutiny in biotechnology governance.

Conclusion

The Public Genome Governance Doctrine seeks to ensure that genomic science advances within the boundaries of constitutional rights, public welfare, and legal accountability. Although Indian law does not recognize a single doctrine under this name, constitutional privacy, informed-consent principles, environmental precaution, and judicial review provide a foundation for its development.

The cases of Puttaswamy, Samira Kohli, Vellore Citizens’ Welfare Forum, A.P. Pollution Control Board, and Gene Campaign offer relevant legal principles. Together, they support a governance framework based on genetic privacy, informed consent, scientific oversight, biosafety, public participation, and accountability.